Abstract
Patients with cancer frequently have an increased serum calcium concentration. Hypercalcemia can occur at any point in the course of the disease and may be the first clue to the presence of malignancy. The condition can be clinically silent and detected only by automated multiphasic blood chemistry determinations; conversely, it can be the most debilitating aspect of the disease. The disorders of calcium homeostasis that underlie this condition are similarly varied. Fortunately, a variety of therapeutic modalities is available for patients who require reduction of their serum calcium.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ackerman, N. B., and Winer, N. The differentiation of primary hyperparathyroidism from the hypercalcemia of malignancy. Ann. Surg 181: 225–231, 1975.
Bassett, I. W., and Steckel, R.J. Imaging techniques in the detection of metastatic disease. Seminars in Oncology 4: 39–52, 1977.
Bender, R. A., and Hansen, H. Hypercalcemia in bronchogenic carcinoma: a prospective study of 200 patients. Ann. Intern. Med 80: 205–208, 1974.
Benson, R. C., Jr.; Riggs, B. L.; Pickard, B. M. et al. Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Ann. Intern. Med 56: 821–826, 1974.
Brereton, H. D.; Halushka, P. V.; Alexander, R. W. et al. Indomethacin-responsive hypercalcemia in a patient with renal cell adenocarcinoma. N. Engl. J. Med 291: 83–85, 1974.
Chakmakjian, Z. H., and Bethune, J. E. Sodium sulfate treatment of hypercalcemia. N. Engl. J. Med 275: 862–869, 1966.
Flower, R. J. Drugs which inhibit prosta-glandin biosynthesis. Pharmacol. Rev 26: 33–67, 1974.
Franklin, R. B., and Tashjian, A. H., Jr. Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat. Endocrinology 97: 140–143. 1975.
Fulmer, D. H.; Dimich, A. B.; Rothschild, E. O. et al. Treatment of hypercalcemia—comparison of intravenously administered phosphate, sulfate, and hydrocortisone. Arch. Intern. Med. 129: 923–930, 1972.
Gordon, G. S.; Cantino, T. J.; Erhardt, L. et al. Osteolytic sterol in human breast cancer. Science 151: 1226–1228, 1966.
Haddad, J. G., Jr.; Couranz, S. J.; and Avioli, L. V. Circulating phytosterols in normal females, lactating mothers, and breast cancer patients. J. Clin. Endocrinol. Metab. 30: 174–180, 1970.
Heath, D. A. Hypercalcemia and malignancy. Ann. Clin. Biochem 13: 555–560. 1976.
Kennedy, B. J. Mithramycin therapy in advanced testicular neoplasms. Cancer 26: 755–766, 1970.
Klein, D. C., and Raisz, L. G. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 86: 1436–1440, 1970.
Lafferty, F. W. Pseudohyperparathyroidism. Medicine 45: 247–260, 1966.
Levant, J. A.; Walsh, J. H.; and Isenberg, J. L. Stimulation of gastric secretion and gastrin release by single oral doses of calcium carbonate in man. N. Engl. J. Med 289: 555–558, 1973.
Lindeman, R. D., and Papper S. Therapy of fluid and electrolyte disorders. Ann. Intern. Med 82: 65–70, 1975.
Lindgarde, F., and Zettervall, O. Hyper-calcemia and normal ionized serum calcium in a case of myelomatosis. Ann. Intern. Med 78: 396–399, 1973.
Mayer, G. P. Habener, J. F.; and Potts, J. T., Jr. Parathyroid hormone secretion in vivo: Demonstration of calcium-independent, nonsuppressible component of secretion. J. Clin. Invest. 57: 678–683, 1976.
Neelon, F. A. CAMP and calcemia Ann. Intern. Med 86: 821–822, 1977.
Mundy, G. R. et al. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N. Engl. J. Med 291: 1041–1046, 1974.
Mundy, G. R. et al. Bone-resorbing activity in supernatants from lymphoid cell lines. N. Engl. J. Med 299: 867–871, 1974.
Omenn, G. S.; Roth, S. L.; and Baker, W. H. Hyperparathyroidism associated with malignant tumors of non-parathyroid origin. Cancer 24: 1004–1012, 1969.
Powell, D. et al. Nonparathyroid humoral hypercalcemia in patients with neo-plastic diseases. N. Engl. J. Med. 289: 247–260, 1966.
Robertson, R. P. et al. Plasma prostaglan-din E in patients with cancer with and without hypercalcemia. J. Clin. Endocrinol. Metab 43: 1330–1335, 1976.
Seyberth, H. W. et al. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N. Engl. J. Med 293: 1278–1282, 1975.
Seyberth, H. W. et al. Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors. Trans. Assoc. Am. Physicians 89: 92–104, 1976.
Shaw, J. W. et al. Urinary cyclic AMP analyzed as a function of the serum, calcium and parathyroid hormone in the differential diagnosis of hyper-calcemia. J. Clin. Invest 59: 14–21, 1977.
Silva, O. L., and Becker, K. L. Salmon calcitonin in the treatment of hyper-calcemia. Arch. Intern. Med 132: 337–339, 1973.
Tashjian, A. H., Jr. Prostaglandins, hyper-calcemia, and cancer. N. Engl. J. Med 293: 1317–1318, 1975.
Tashjian, A. H., Jr. et al. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E2—a new model for the hypercalcemia of cancer. J. Exp. Med. 136: 1329–1343, 1972.
Tashjian, A. H., Jr. et al. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. Prostaglandins 3: 515–524, 1973.
Tashjian, A. H., Jr. et al. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells. Nature 258: 739, 1975.
Vaughn, C. B., and Vaitkevicius, V. K. The effects of calcitonin in hypercalcemia in patients with malignancy. Cancer 34: 1268–1271, 1974.
Williams, R. H., ed Textbook of endocrinology. 4th ed, p. 312. Philadelphia: W. B. Saunders Co., 1968.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 G.K. Hall & Co.
About this chapter
Cite this chapter
Wolff, J. (1980). Hypercalcemia of Malignancy. In: Lokich, J.J. (eds) Clinical Cancer Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7235-6_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-7235-6_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-7237-0
Online ISBN: 978-94-011-7235-6
eBook Packages: Springer Book Archive